title: Impact of histamine and histamine2 receptor antagonists on quality of life and antitumour responses: results of a pilot trial.
authors.forename: S
authors.initials: S
authors.lastname: Milanese
authors.forename: L A
authors.initials: LA
authors.lastname: Hansen
authors.forename: C E
authors.initials: CE
authors.lastname: Desch
authors.forename: C
authors.initials: C
authors.lastname: Honeycutt
authors.forename: F
authors.initials: F
authors.lastname: Tesfaye
authors.forename: T J
authors.initials: TJ
authors.lastname: Smith
mesh_terms: D000328:Adult; D000368:Aged; D004311:Double-Blind Method; D006632:Histamine / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D010865:Pilot Projects; D011788:Quality of Life; D011899:Ranitidine / Q000627:therapeutic use*
chemical_list: D006635:Histamine H2 Antagonists; D006632:Histamine; D011899:Ranitidine